Phosphorus is a spin‑out from Recombine that develops genetic tests and a data platform aimed at identifying causes of infertility in couples. The company offers direct-to-consumer and clinic-facing tests and provides a FertilityMap product that analyzes hundreds of clinical variables and thousands of genetic variants alongside personal, pregnancy and family medical history. Phosphorus combines new Phosphorus test data with the Recombine data map, which customers can opt in to share anonymously, to detect signals missed by smaller datasets. Physicians and researchers can access the FertilityMap to conduct research, while fertility clinics and consumers can use the platform and interpretation resources to inform diagnosis and treatment decisions. The company aims to develop predictive algorithms to inform infertility diagnosis, prognosis, and treatment to help more families achieve successful pregnancies. Phosphorus raised a $10 million Series A led by FirstMark.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2016